Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells

Sorafenib has attracted much attention as the first drug approved by the FDA for the treatment of advanced hepatocellular carcinoma (HCC). Because of the drug tolerance, the overall outcomes were far from satisfactory. Current studies suggest that changes in glucose metabolism induced by sorafenib a...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyu Yan (Author), Rui Tian (Author), Jicheng Sun (Author), Yuanxin Zhao (Author), Buhan Liu (Author), Jing Su (Author), Minghua Li (Author), Wei Sun (Author), Xuesong Xu (Author)
Format: Book
Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available